Edwards Lifesciences (EW) EBT Growth (3y) (2012 - 2026)
Edwards Lifesciences (EW) EBT Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.75 Bn | 194.14 Bn | 7.27 Bn | -2.34% |
| 2 | Stryker | 127.36 Bn | 123.88 Bn | 4.50 Bn | 20.27% |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 5.75% |
| 4 | Boston Scientific | 73.20 Bn | 72.66 Bn | 3.85 Bn | 35.51% |
| 5 | Edwards Lifesciences | 52.10 Bn | 47.85 Bn | 1.35 Bn | 23.63% |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | 25.85% |
| 7 | GE HealthCare Technologies | 33.77 Bn | 31.66 Bn | 2.18 Bn | 6.73% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 89.20% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 17.92% |
| 10 | Zimmer Biomet Holdings | 19.20 Bn | 18.79 Bn | 1.54 Bn | -2.68% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 23.63% |
| Mar 31, 2026 | 4.82% |
| Dec 31, 2025 | -24.66% |
| Sep 30, 2025 | -5.07% |
| Jun 30, 2025 | -4.86% |
| Mar 31, 2025 | -0.17% |
| Dec 31, 2024 | 1.21% |
| Sep 30, 2024 | 1.00% |
| Jun 30, 2024 | -11.04% |
| Mar 31, 2024 | -1.57% |
| Dec 31, 2023 | 1.03% |
| Sep 30, 2023 | 2.09% |
| Jun 30, 2023 | 53.76% |
| Mar 31, 2023 | 3.03% |
| Dec 31, 2022 | -12.49% |
| Sep 30, 2022 | 10.52% |
| Jun 30, 2022 | 19.65% |
| Mar 31, 2022 | 16.19% |
| Dec 31, 2021 | 495.39% |
| Sep 30, 2021 | 16.27% |